G. Michael Felker

Feb 20, 2024 | onlinelibrary.wiley.com | Pierpaolo Pellicori |G. Michael Felker |John G.F. Cleland

Letter to the Editor Reply to ‘Vasodilators in congestive heart failure: The perfect weapon aiming just off the target?’ Pierpaolo Pellicori,  Corresponding Author Pierpaolo Pellicori School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK Corresponding author. Email: [email protected] for more papers by this authorG. Michael Felker,  G.

Jan 1, 2024 | jacc.org | Josephine Harrington |G. Michael Felker |Ildiko Lingvay |Neha J. Pagidipati

References1. "Twenty years of cardiovascular complications and risk factors in patients with type 2 diabetes: a nationwide Swedish cohort study". Circulation . 2023;147:1872-1886. 2. "Obesity and cardiovascular disease: a scientific statement from the American Heart Association". Circulation . 2021;143:e984-e1010. 3. "Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction". Circulation . 2017;136:6-19. 4.

Nov 11, 2023 | jamanetwork.com | G. Michael Felker |Joseph Rogers

Aspirin and Hemocompatibility Events With an LVAD in Advanced Heart Failure Mandeep R. Mehra, MBBS, MSc; Ivan Netuka, MD, PhD; Nir Uriel, MD, MSc; Jason N. Katz, MD, MS; Francis D. Pagani, MD, PhD; Ulrich P. Jorde, MD; Finn Gustafsson, MD, PhD, DMSci; Jean M. Connors, MD; Peter Ivak, MD, PhD; Jennifer Cowger, MD, MS; John Ransom, MD; Aditya Bansal, MD; Koji Takeda, MD, PhD; Richa Agarwal, MD; Mirnela Byku, MD, PhD; Michael M.